Jaguar Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Lincoln Alternative Strategies LLC reports zero beneficial ownership in Jaguar Health, Inc. common stock, signaling a complete divestment or reduction below the 5% reporting threshold.
NASDAQ
Joshua Mailman has reported a beneficial ownership of 8.4% of Jaguar Health, Inc.'s common stock, totaling 587,320 shares.
NASDAQ
SCHEDULE 13G/A: Streeterville Capital Divests Entire Jaguar Health Stake
Streeterville Capital LLC and related entities report 0% beneficial ownership in Jaguar Health, Inc., indicating a full divestment of their previously reported stake.
NASDAQ
Iliad Research & Trading, L.P. and affiliated entities have disclosed a 9.8% beneficial ownership stake in Jaguar Health, Inc. common stock.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. disclose a 4.6% beneficial ownership stake in Jaguar Health, Inc. common stock.
NASDAQ
Lincoln Alternative Strategies LLC has reported a significant 18.92% beneficial ownership stake in Jaguar Health, Inc. common stock.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a 9.9% beneficial ownership stake in Jaguar Health, Inc., primarily through warrants.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. filed an amended Schedule 13G to correct an administrative error, disclosing a beneficial ownership of 9.9% in Jaguar Health, Inc.
NASDAQ
SCHEDULE 13G: CVI Investments and Heights Capital Management Disclose 9.9% Passive Stake in Jaguar Health
CVI Investments, Inc., managed by Heights Capital Management, Inc., has disclosed a passive 9.9% beneficial ownership stake in Jaguar Health, Inc., totaling 103,912 shares.
NASDAQ
SCHEDULE 13G: Investment Group Discloses 4.99% Stake in Jaguar Health, Inc. Following Securities Purchase Agreement
Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have jointly disclosed a 4.99% beneficial ownership stake in Jaguar Health, Inc. as of May 27, 2025, stemming from a recent Securities Purchase Agreement.
NASDAQ
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has reported a passive beneficial ownership of 6.7% in Jaguar Health, Inc., totaling 45,478 shares of common stock.
NASDAQ
John Fife and Fredrick Waid have jointly disclosed a passive beneficial ownership of 9.9% in Jaguar Health, Inc., totaling 1,290,000 shares of common stock.